
Search
Selected Filter
Filter Results
Displaying 21–30 of 304 research results
-
Apr 10, 2023
Age-Related Macular Degeneration Research Advances
Recent developments in research on age-related macular degeneration.
-
Apr 10, 2023
Retinitis Pigmentosa Research Advances
Recent developments in research on retinitis pigmintosa.
-
Apr 10, 2023
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Apr 10, 2023
Usher Syndrome Research Advances
Recent developments in research on Usher Syndrome.
-
Mar 30, 2023
Most participants with advanced retinitis pigmentosa (RP) in the trial had improved navigation and/or object discrimination in reduced lighting conditions
-
Feb 18, 2023
Geographic atrophy (GA) is the advanced form of dry age-related macular degeneration (AMD) which causes blindness in one million people in the United States and 5 million worldwide.
This is the first time that a treatment has been approved for this leading cause of blindness.
-
Jan 3, 2023
Opus Genetics Acquires Rights to Gene Therapies for BEST1 and RP (RHO)
The company plans to seek clinical trial authorization for the BEST1 gene therapy during the second half of 2023
-
Dec 2, 2022
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
The emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
-
Dec 2, 2022
Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
The LCA5 gene therapy will be the first emerging Opus treatment to move into a human study
-
Nov 18, 2022
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
The company is seeking a partner to move the LCA10 program forward